Zahra Aghazadeh Selected Research

guluronic acid

2/2020	Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORγt, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients.
12/2019	Effects of guluronic acid (G2013) on gene expression of TLR2, TLR4, MyD88, TNF-α and CD52 in multiple sclerosis under in vitro conditions.
4/2017	Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zahra Aghazadeh Research Topics

Disease

10	Rheumatoid Arthritis 02/2022 - 01/2017
7	Multiple Sclerosis 01/2022 - 01/2017
4	Inflammation (Inflammations) 09/2021 - 01/2018
3	Ankylosing Spondylitis 01/2020 - 01/2018
2	Wounds and Injuries (Trauma) 03/2022 - 01/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2020 - 01/2017
1	Dental Caries (Decay, Dental) 08/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	COVID-19 01/2022
1	Relative Energy Deficiency in Sport 11/2021
1	Chronic Progressive Multiple Sclerosis 10/2021
1	Infections 09/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Leukocytosis (Pleocytosis) 10/2017
1	Body Weight (Weight, Body) 04/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017

Drug/Important Bio-Agent (IBA)

14	mannuronic acidIBA 02/2022 - 01/2017
7	Pharmaceutical PreparationsIBA 01/2022 - 06/2018
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2021 - 10/2017
5	Therapeutic UsesIBA 10/2019 - 04/2017
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 02/2018
3	guluronic acidIBA 02/2020 - 04/2017
2	Cisplatin (Platino)FDA LinkGeneric 06/2020 - 01/2017
2	Interleukin-4 (Interleukin 4)IBA 02/2020 - 01/2017
1	Pit and Fissure Sealants (Dental Sealants)IBA 08/2022
1	FluoridesIBA 08/2022
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 03/2022
1	NanogelsIBA 03/2022
1	GelatinIBA 03/2022
1	Drug CombinationsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	camostatIBA 01/2022
1	ThapsigarginIBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	remdesivirIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	10-propargyl-10-deazaaminopterin FDA Link 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	Alkaline PhosphataseIBA 11/2021
1	alizarinIBA 11/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	CurcuminIBA 09/2021
1	ChemokinesIBA 01/2021
1	AntioxidantsIBA 01/2021
1	chrysinIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Diclofenac (SR 38)FDA LinkGeneric 01/2020
1	CytokinesIBA 02/2018
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2018
1	D-Aspartic Acid (D Aspartate)IBA 07/2017
1	Biological ProductsIBA 01/2017
1	AlginatesIBA 01/2017

Therapy/Procedure

3	Therapeutics 08/2022 - 10/2017
2	Oral Administration 01/2020 - 10/2019